References
- Berg GEB, Nyström EH, Jacobsson L, Lindberg S, Lindstedt RG, Mattsson S, et al. Radioiodine treatment of hyperthyroidism in a pregnant woman. J Nucl Med 1998; 39: 357–61
- Evans PMS, Webster J, Evans WD, Bevant JS, Scanlon MF. Radioiodine treatment in unsuspected pregnancy. Clin Endocrinol 1998; 48: 281–3
- Elsasser U, Henrichs K, Kaul A, Reddy AR, Roedler HD. Specific absorbed fractions and S-factors for calculating absorbed dose to embryo and fetus. In: Schlafke-Stelson AT, Watson EE, Proceedings in the fourth international radiopharmaceutical dosimetry symposium. Oak Ridge, TN: Oak Ridge Associated Universities; 1986. p 155–165.
- Watson E. Radiation absorbed dose to the human fetal thyroid. In: Schlafke-Stelson AT, Watson EE, Proceedings of the fifth international radiopharmaceutical dosimetry symposium. Oak Ridge, TN: Oak Ridge Associated Universities; 1991. p 179–187.
- Watson WS. Radioiodine therapy and pregnancy. J Nucl Med 2005; 46: 1408–9
- Sutton JM. Charge variants in serum and urine hCG. Clin Chim Acta 2004; 341: 199–203
- Steier JA, Myking OL, Bergsjo P. Correlation between fetal sex and human chorionic gonadotropin in peripheral maternal blood and amniotic fluid in second and third trimester normal pregnancies. Acta Obstet Gyneol Scand 1999; 78: 367–71
- Stoffer SS, Hamburger JI. Inadvertent 131I therapy for hyperthyroidism in the first trimester of pregnancy. J Nucl Med 1976; 17: 146–9
- Mitchell ML, Klein RZ. The sequelae of untreated maternal hypothyroidism. Eur J Endocrinol 2004; 151: U45–U48
- ICRP 88. Doses to the embryo and fetus from intakes of radionuclides by the mother. Ann ICRP 2001;31:1–3.
- Ho SSY, Metreweli C. Normal fetal thyroid volume. Ultrasound Obstet Gynecol 1998; 11: 118–22
- Cardonic E, Iacobucci A. Use of chemotherapy during human pregnancy. Lancet Oncology 2004; 5: 283–91